Kaitlyn D’Onofrio

DocwireNews

The Food and Drug Administration (FDA) addressed the &ldquo;epidemic&rdquo; of minors using electronic cigarettes and announced it is cracking down on the manufacturers, calling the action &ldquo;the largest coordinated tobacco compliance effort in FDA&rsquo;s history.&rdquo;&nbsp;FDA Commissioner Dr. Scott Gottlieb said if the companies do not come up with a plan to address e-cig sales to minors in 60 days, they may have to stop selling some or&nbsp;all of&nbsp;their products entirely.&nbsp;&ldquo;This may require these brands to revise their sales and marketing practices, including online sales; to stop distributing their products to retailers who sell to kids; and to remove some or all of their flavored e-cig products from the market until they receive premarket authorization and otherwise meet applicable requirements,&rdquo; Gottlieb wrote.&nbsp;<blockquote class="twitter-tweet" data-width="500" data-dnt="true">
I&rsquo;m glad the FDA has agreed with my repeated calls to crack down on e-cigarette companies that peddle kid-appealing flavors. This is a health epidemic, and FDA must follow through with today&rsquo;s announcement to protect youth from these dangerous and addictive products. <a href="https://t.co/2nlAOWK2xC">https://t.co/2nlAOWK2xC</a>
&mdash; Senator Dick Durbin (@SenatorDurbin) <a href="https://twitter.com/SenatorDurbin/status/1039895919565651968?ref_src=twsrc%5Etfw">September 12, 2018</a>
</blockquote><script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script>&ldquo;In the meantime, we&rsquo;ll be investigating their marketing and sales practices, including with boots on the ground inspections. The FDA is going to continue to work to find out why so many kids are using and abusing these products.&rdquo;&nbsp;Five companies that currently account for more than 97% of e-cig sales nationwide were contacted&nbsp;directly:&nbsp;JUUL,&nbsp;Vuse,&nbsp;MarkTen,&nbsp;blu&nbsp;e-cigs, and Logic.&nbsp;<a href="https://twitter.com/SGottliebFDA/status/1039881610714378241">https://twitter.com/SGottliebFDA/status/1039881610714378241</a>Over the last few years, e-cig use among teens has sharply increased. According to research published in the&nbsp;<a href="https://www.nejm.org/doi/full/10.1056/NEJMp1805758?query=featured_home">New England Journal of Medicine</a>, high schoolers who reported using e-cigs within the previous month went from less than 2% in 2011 to 16% by 2015.&nbsp;The&nbsp;<a href="https://e-cigarettes.surgeongeneral.gov/knowtherisks.html">Surgeon General&rsquo;s Report</a>&nbsp;on e-cigarette use among young people reported, &ldquo;Besides increasing the possibility of addiction and long-term harm to brain development and respiratory health, e-cigarette use is associated with the use of other tobacco products that can do even more damage to the body. Even breathing e-cigarette aerosol that someone else has exhaled poses potential health risks.&rdquo;&nbsp;The FDA&rsquo;s correspondence pertains to&nbsp;a number of&nbsp;products on the market, according to Gottlieb.&nbsp;&ldquo;We&rsquo;re also re-examining the enforcement discretion we currently exercise for other e-cig products currently on the market without authorization. Today&rsquo;s letters target the&nbsp;five dominant&nbsp;e-cig manufacturers, including those whose products were purchased by kids in our enforcement blitz. But the policy reconsiderations apply to the entire category,&rdquo; Gottlieb wrote.&nbsp;&ldquo;JUUL Labs will work proactively with FDA&nbsp;in response to its request,&rdquo; a&nbsp;spokeswoman for JUUL told The New York Times in an email. &ldquo;We are committed to preventing underage use of our product, and we want to be part of the solution in keeping e-cigarettes out of the hands of young people.&rdquo;&nbsp;The FDA also sent over 1,100 letters to stores&nbsp;that sell e-cigs, as well as issued 131 civil money penalties to ones that did not follow protocol on sales to minors.&nbsp;Sources: <a href="https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm620185.htm">FDA</a>, <a href="https://www.nytimes.com/2018/09/12/health/juul-fda-vaping-ecigarettes.html?action=click&amp;contentCollection=health&amp;region=rank&amp;module=package&amp;version=highlights&amp;contentPlacement=1&amp;pgtype=sectionfront">NY Times</a>&nbsp;

Jordana Jampel

Positive Preliminary Results From Phase 1 Trial of Dopaminergic Neuron Graft for Parkinson’s Disease

Dementia

Bradley Warady, MD

Joel M. Topf, MD, FACP

2025 Hume Award Winner Is Dedicated to Children’s Care

NKF Spring Clinical Meetings 2025

Distant Brain Metastases in Cutaneous Melanoma May Be Mitigated With Multiple Pathway Inhibitors

Melanoma

Latest News

FDA Addresses ‘Epidemic’ of Teen E-Cigarette Use

Pulmonology

The Food and Drug Administration (FDA) addressed the “epidemic” of minors using electronic cigarettes and announced it is cracking down on the manufacturers, calling the ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe